Clinical Trials
- Other Cancers
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate Pembrolizumab Versus Placebo as Adjuvant Therapy Following Surgery and Radiation in Participants With High-risk Locally Advanced Cutaneous Squamous Cell Carcinoma (LA cSCC) (KEYNOTE-630)
- Ages18 years and older
- GenderBoth
- Heart/Cardiovascular
Mechanisms of Diuretic Resistance in Heart Failure (MsDR)
- Ages18 years and older
- GenderBoth
- Heart/Cardiovascular
Randomized Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients who Present with Symptomatic Heart Failure with Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study
- Ages18 years and older
- GenderBoth
- Heart/Cardiovascular
Pragmatic Trial Of Alerts for Use of Mineralocorticoid Receptor Antagonists (PROMPT-MRA)
- Ages18 years and older
- GenderBoth
- Heart/Cardiovascular, Genetics
Congenital Heart Disease GEnetic NEtwork Study (CHD GENES)
- GenderBoth
- Heart/Cardiovascular, Endocrine System
Screening for Cardiac Amyloidosis Using Nuclear Imaging for Minority Populations (SCAN-MP)
- Ages60 years and older
- GenderBoth
- Heart/Cardiovascular
Transcatheter Aortic Valve Replacement to UNload the Left Ventricle in Patients With ADvanced Heart Failure (TAVR UNLOAD)
- Ages18 years and older
- GenderBoth
- Head and Neck Cancers
A Phase II Randomized Trial of Adjuvant Therapy With Pembrolizumab After Resection of Recurrent/Second Primary Head and Neck Squamous Cell Carcinoma With High Risk Features
- Lung Cancer
A Randomized Phase II Study of INC280 (Capmatinib) Plus Osimertinib With or Without Ramucirumab in Participants With EGFR-Mutant, MET-Amplified Stage IV or Recurrent Non-Small Cell Lung Cancer (Lung-MAP Sub-Study)
- Heart/Cardiovascular
Double blind randomized autologous stem cell trial treatment for peripheral arterial disease (PAD) with critical limb threatening ischemia
- Ages18 years and older
- GenderBoth